Business

MedMen / Ascend dispute escalates

By Alex Halperin
Jan 6, 2022
story-image
MSO Ascend Wellness Holdings claimed MSO MedMen had challenged the authority of New York regulators. The accusation comes after MedMen announced, earlier this week, that it would terminate a deal to be sell more than 86% of its New York...

This content is FREE for registered users.

To view this content you need to register as a Weedweek member.

If you are already a member please login below.

or